VRPX - Virpax Pharmaceuticals, Inc.
0.6695
-0.551 -82.226%
Share volume: 2,782,368
Last Updated: 04-03-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.22
-0.55
-0.45%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-14-2024 | 03-03-2025 | |
| Cash flow financing | 453.951 K | 1.648 M | 2.616 M | 4.367 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | -154.226 K | |
| Cash flow | -7.275 M | 0.000 | 0.000 | 0.000 | |
| Net income | -3.220 M | -3.450 M | -2.006 M | -3.390 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -7.275 M | 4.598 K | -1.854 M | 1.496 M |